ACA
FOLD

Apis Capital Advisors’s Amicus Therapeutics FOLD Stock Holding History

Apis Capital Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$4.15M Sell
296,601
-56,399
-16% -$885K 5.74% 4
2015
Q2 		$5M Buy
353,000
+91,000
+35% +$1.09M 5.61% 6
2015
Q1 		$2.63M Buy
+262,000
New +$2.31M 3.6% 10

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Apis Capital Advisors's FOLD Position: Q3 2015 in Review

Apis Capital Advisors reduced its Amicus Therapeutics (FOLD) stake by 16% in Q3 2015, selling an estimated $885K and leaving 296,601 shares worth $4.15M. The position accounts for 5.74% of the portfolio, ranked #4.

Apis Capital Advisors first reported a position in FOLD in Q1 2015 and has held it in 3 quarters since. The position peaked at $5M in Q2 2015. 147 funds tracked by Wall St. Rank hold FOLD as of Q3 2015.

  • Apis Capital Advisors held 296,601 shares of Amicus Therapeutics worth $4.15M as of Q3 2015.
  • Apis Capital Advisors sold 56,399 Amicus Therapeutics shares in Q3 2015, an estimated $885K.
  • Amicus Therapeutics made up 5.74% of Apis Capital Advisors's portfolio in Q3 2015, its #4 holding.
  • Apis Capital Advisors first reported a position in Amicus Therapeutics in Q1 2015 and has held it in 3 quarters since.
  • Apis Capital Advisors's Amicus Therapeutics position peaked at $5M in Q2 2015.
  • 147 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2015.

Based on Apis Capital Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.